These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1190 related articles for article (PubMed ID: 25654603)

  • 1. Therapeutic genome editing: prospects and challenges.
    Cox DB; Platt RJ; Zhang F
    Nat Med; 2015 Feb; 21(2):121-31. PubMed ID: 25654603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Therapeutic Genome Editing in China.
    Yang Y; Wang Q; Li Q; Men K; He Z; Deng H; Ji W; Wei Y
    Hum Gene Ther; 2018 Feb; 29(2):136-145. PubMed ID: 29446996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in targeted genome editing.
    Perez-Pinera P; Ousterout DG; Gersbach CA
    Curr Opin Chem Biol; 2012 Aug; 16(3-4):268-77. PubMed ID: 22819644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic genome editing with engineered nucleases.
    Haas SA; Dettmer V; Cathomen T
    Hamostaseologie; 2017 Jan; 37(1):45-52. PubMed ID: 28070592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted genome editing tools for disease modeling and gene therapy.
    Cai M; Yang Y
    Curr Gene Ther; 2014 Feb; 14(1):2-9. PubMed ID: 24665839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome engineering in human cells.
    Song M; Kim YH; Kim JS; Kim H
    Methods Enzymol; 2014; 546():93-118. PubMed ID: 25398337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases.
    Kaur B; Perea-Gil I; Karakikes I
    Curr Cardiol Rep; 2018 Jun; 20(7):58. PubMed ID: 29860642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic editing of hepatocyte genome in vivo.
    Ruiz de Galarreta M; Lujambio A
    J Hepatol; 2017 Oct; 67(4):818-828. PubMed ID: 28527665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Practical Guide to Genome Editing Using Targeted Nuclease Technologies.
    Porter SN; Levine RM; Pruett-Miller SM
    Compr Physiol; 2019 Mar; 9(2):665-714. PubMed ID: 30873595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-viral delivery of genome-editing nucleases for gene therapy.
    Wang M; Glass ZA; Xu Q
    Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.
    Epstein BE; Schaffer DV
    Adv Exp Med Biol; 2017; 1016():29-42. PubMed ID: 29130152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in genome editing of stem cells for drug discovery and therapeutic application.
    Lee J; Bayarsaikhan D; Bayarsaikhan G; Kim JS; Schwarzbach E; Lee B
    Pharmacol Ther; 2020 May; 209():107501. PubMed ID: 32061705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-mediated genome editing: From basic research to translational medicine.
    Jacinto FV; Link W; Ferreira BI
    J Cell Mol Med; 2020 Apr; 24(7):3766-3778. PubMed ID: 32096600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing.
    Hotta A; Yamanaka S
    Annu Rev Genet; 2015; 49():47-70. PubMed ID: 26407033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Progress in Therapeutic Gene Editing for Monogenic Diseases.
    Prakash V; Moore M; Yáñez-Muñoz RJ
    Mol Ther; 2016 Mar; 24(3):465-74. PubMed ID: 26765770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic correction using engineered nucleases for gene therapy applications.
    Li HL; Nakano T; Hotta A
    Dev Growth Differ; 2014 Jan; 56(1):63-77. PubMed ID: 24329887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome editing in pluripotent stem cells: research and therapeutic applications.
    Deleidi M; Yu C
    Biochem Biophys Res Commun; 2016 May; 473(3):665-74. PubMed ID: 26930470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic gene editing: delivery and regulatory perspectives.
    Shim G; Kim D; Park GT; Jin H; Suh SK; Oh YK
    Acta Pharmacol Sin; 2017 Jun; 38(6):738-753. PubMed ID: 28392568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery methods for site-specific nucleases: Achieving the full potential of therapeutic gene editing.
    Liu J; Shui SL
    J Control Release; 2016 Dec; 244(Pt A):83-97. PubMed ID: 27865852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.